These processes have all been associated with DNA damage accumulation and implicated in melanoma, where suppression of Caspase-9 and p16 and over-stimulation of LCB3 have been linked to melanomagenesis, contributing to disease progression and resistance to therapy (56–65). The gene discussed is SPTLC3; the disease is melanoma.